Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Head-to-head evidence comparison — which supplement is right for you?
Ashwagandha wins 2 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Likely helps
14 of 14 studies with measurable effects showed benefit.
Top outcomes
Verdict
Likely helps
3 of 3 studies with measurable effects showed benefit.
Top outcomes
300-600mg daily (standardized extract)
Morning for daytime stress, Evening for sleep support
KSM-66 or Sensoril standardized extract
200-500mg extract (standardized to 15-20% L-DOPA)
Morning or early afternoon, On empty stomach or with protein
Standardized extract (15-20% L-DOPA)
2-4 weeks
2-4 weeks
2-4 weeks
First week
1-4 weeks
8-12 weeks
4-8 weeks
Effects of Ashwagandha (Withania Somnifera) on stress and anxiety: A systematic review and meta-analysis
Explore (NY) (2024) · Meta analysis · n=873
Significant effect on the Perceived Stress Scale (PSS) (MD = -4.72, 95 % CI = [-8.45 to -0.99]).
Effects of Withania somnifera Extract in Chronically Stressed Adults: A Randomized Controlled Trial
Nutrients (2024) · Rct · n=131
Our findings demonstrate the stress-reduction capabilities of this well-characterized aqueous extract of WS (root and leaf) at the low dose of 125 mg/day, in a dose-dependent manner, via the modulation of the HPA axis.
Plant-derived nootropics and human cognition: A systematic review
Critical reviews in food science and nutrition (2023) · Systematic review
Bacopa monnieri improves language, learning and memory.
Levodopa and Plant-Derived Bioactive Compounds in Parkinson's Disease: Mechanisms, Efficacy, and Future Perspectives
CNS neuroscience & therapeutics (2025) · Systematic review
Although levodopa is indispensable for the symptomatic management of PD, emerging evidence supports the integration of plant-derived bioactive compounds as adjunct therapies with disease-modifying potential.
Phytochemicals in Parkinson's Disease: a Pathway to Neuroprotection and Personalized Medicine
Cell biochemistry and biophysics (2025) · Systematic review
This review provides a comprehensive overview of the neuroprotective potential of phytochemicals in PD management, examining the mechanisms underlying PD pathogenesis and emphasizing neuroprotection.
Natural angiotensin converting enzyme inhibitors: A safeguard against hypertension, respiratory distress syndrome, and chronic kidney diseases
Phytotherapy research : PTR (2023) · Systematic review
Alkaloids, amino acids, anthocyanidins, flavonoids, glucosinolates, isoflavonoids, phenolic acids, polyphenolics, and triterpenoids are among the bioactive metabolites pocessing an impressive ACE inhibitory activity.
Based on meta-analysis showing significant HAM-A score reduction (p=0.0007) and RCT evidence at 125mg dose. High heterogeneity (I2=98%) in pooled analysis suggests variable response. Extract standardization affects bioavailability.
Based on systematic reviews examining L-DOPA content for PD management. Tolerance development (40% prevalence) limits long-term effectiveness. Nausea is common side effect. Studies focus on adjunct therapy rather than monotherapy.
AI-estimated from published studies. Interpret as directional guidance.
Ashwagandha has a higher evidence score (7.5/10 vs 6/10) and wins in 2 of 3 categories.
For reduce anxiety & stress, Ashwagandha has a higher relevance score (95 vs 50).
No known interactions between Ashwagandha and Mucuna Pruriens have been documented in our database. However, always consult a healthcare provider before combining supplements.